Crossmark

Pharmacological inactivation of a non-canonical gp130 signaling arm attenuates chronic systemic inflammation and multimorbidity induced by a high-fat diet

Crossref DOI link: https://doi.org/10.1038/s41598-024-82414-7

Published Online: 2024-12-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Youngjoo

Tassey, Jade

Sarkar, Arijita

Levi, Jonathan N.

Lee, Siyoung

Liu, Nancy Q.

Drake, Andrew C.

Nguyen, Falisha

Magallanes, Jenny

Stevic, Una

Lu, Jinxiu

Ge, Dawei

Tang, Hanhan

Mkaratigwa, Tadiwanashe

Yang, Jichen

Bian, Fangzhou

Shkhyan, Ruzanna

Bonaguidi, Michael A.

Evseenko, Denis
Funding

Funding for this research was provided by:

U.S. Department of Defense (W81XWH-13-1- 0465 (DE))

National Institute of Dental and Craniofacial Research (R01AR071734)

National Institute of Aging (R01AG058624)

National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (U24DE026914)
License Information

Text and Data Mining valid from 2024-12-28

Version of Record valid from 2024-12-28
More Information

Article History

Received: 22 July 2024

Accepted: 5 December 2024

First Online: 28 December 2024

Declarations

:

: Denis Evseenko is a co-founder and major stockholder of Carthronix Inc. All other authors declare no competing interests.

Document is current

Any future updates will be listed below